Literature DB >> 32816165

Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.

Mar Carmona-Abellan1, Ivan Martinez-Valbuena2,3, Irene Marcilla2,3, Carla DiCaudo4, Isabel Gil3,5, Jorge Nuñez6, Maria-Rosario Luquin3,6.   

Abstract

The olfactory bulb (OB) seems to be the first affected structure in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Lewy body dementia (LBD). Deposits of protein aggregates, increased dopaminergic neurons, and decreased cholinergic inputs have all been described in the OB of these diseases. We investigated here the contribution of the activated microglial cells to the increased deposits of protein aggregates. We quantified the number of activated microglial cells and astrocytes in the OB of patients with histological diagnosis of PD (n = 5), AD (n = 13), and LBD (n = 7) and aged-matched controls (n = 8). Specific consensus diagnostic criteria were applied for AD, LBD, and PD. Protein aggregates were scored in the OB as grade 0, none; grade 1, mild; grade 2, moderate; and grade 3, severe. OB sections from the 33 subjects were stained with specific antibodies markers for reactive astrocytes (GFAP) and microglial cells (Iba1 and HLA-DR). The total number of Iba1-ir (Iba-immunoreactive) and HLAD-DR cells was estimated by stereological analysis, while quantification of astrocytes was performed by GFAP optical density. Statistical analysis was done using the Stata 12.0 software. The number of microglia and activated microglia cells (HLA-RD-ir) was increased in patients with neurodegenerative diseases (p < 0.05). Moreover, the density of GFAP-ir cells was higher in the OB of patients. Neither the number of microglia cells nor the density of astrocytes correlated with the number of b-amyloid and alpha-synuclein deposits, but the density of Iba1-ir cells correlated with the number of p-Tau aggregates. Activated microglial cells and reactive astrocytes are present in the OB of patients with neurodegenerative diseases. The lack of correlation between the number of activated microglia cells and protein deposits indicate that they might independently contribute to the degenerative process. The presence of microglia is related to phosphorylated Tau deposits in neurodegenerative diseases.

Entities:  

Keywords:  Aggregates; Astrocytes; Glial cells; Lewy body; Microglia; Neurodegeneration; Olfactory bulb; Parkinson

Mesh:

Substances:

Year:  2020        PMID: 32816165     DOI: 10.1007/s10072-020-04686-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  Neuroinflammation in Parkinson's disease.

Authors:  Etienne C Hirsch; Sheela Vyas; Stéphane Hunot
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.

Authors:  Evelien Huisman; Harry B M Uylings; Piet V Hoogland
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

Review 3.  Pathogenesis of Parkinson's disease.

Authors:  Etienne C Hirsch; Peter Jenner; Serge Przedborski
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

4.  Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment.

Authors:  Marco Fusetti; Alessandra B Fioretti; Fabrizio Silvagni; Maria Simaskou; Patrizia Sucapane; Stefano Necozione; Alberto Eibenstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2010-04

5.  Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

Authors:  J Attems; K A Jellinger
Journal:  Clin Neuropathol       Date:  2006 Nov-Dec       Impact factor: 1.368

6.  Palatability study of two commonly-used bulk-additives.

Authors:  S Perot; C Buckley; J F Fielding
Journal:  Ir Med J       Date:  1985-05

Review 7.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

8.  Cognitive function in Japanese centenarians according to the Mini-Mental State Examination.

Authors:  Hiroki Inagaki; Yasuyuki Gondo; Nobuyoshi Hirose; Yukie Masui; Koji Kitagawa; Yasumichi Arai; Yoshinori Ebihara; Ken Yamamura; Michiyo Takayama; Susumu Nakazawa; Ken-ichiro Shimizu; Akira Homma
Journal:  Dement Geriatr Cogn Disord       Date:  2009-07-15       Impact factor: 2.959

Review 9.  Olfactory system pathology as a model of Lewy neurodegenerative disease.

Authors:  John E Duda
Journal:  J Neurol Sci       Date:  2009-09-23       Impact factor: 3.181

10.  Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.

Authors:  Karlijn J Doorn; Andrea Goudriaan; Carla Blits-Huizinga; John G J M Bol; Annemieke J Rozemuller; Piet V J M Hoogland; Paul J Lucassen; Benjamin Drukarch; Wilma D J van de Berg; Anne-Marie van Dam
Journal:  Brain Pathol       Date:  2013-10-28       Impact factor: 6.508

View more
  3 in total

Review 1.  Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer's Disease.

Authors:  Da Hae Jung; Gowoon Son; Oh-Hoon Kwon; Keun-A Chang; Cheil Moon
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

Review 2.  Neuroinflammation in Dementia-Therapeutic Directions in a COVID-19 Pandemic Setting.

Authors:  Mateusz Łuc; Marta Woźniak; Joanna Rymaszewska
Journal:  Cells       Date:  2022-09-22       Impact factor: 7.666

3.  Neuropathology changed by 3- and 6-months low-level PM2.5 inhalation exposure in spontaneously hypertensive rats.

Authors:  Hsiao-Chi Chuang; Hsin-Chang Chen; Pei-Jui Chai; Ho-Tang Liao; Chang-Fu Wu; Chia-Ling Chen; Ming-Kai Jhan; Hui-I Hsieh; Kuen-Yuh Wu; Ta-Fu Chen; Tsun-Jen Cheng
Journal:  Part Fibre Toxicol       Date:  2020-11-26       Impact factor: 9.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.